272 related articles for article (PubMed ID: 204536)
1. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat.
Carter RF; Bitar KN; Zfass AM; Makhlouf GM
Gastroenterology; 1978 Apr; 74(4):726-30. PubMed ID: 204536
[TBL] [Abstract][Full Text] [Related]
2. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
Nakaki T; Nakadate T; Yamamoto S; Kato R
J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin inhibits VIP- and forskolin-stimulated cyclic AMP accumulation in enterocytes from rat jejunum.
Juarranz MG; Guijarro LG; Lopez-Ruiz MP; Prieto JC
Epithelial Cell Biol; 1992 Apr; 1(2):65-9. PubMed ID: 1364040
[TBL] [Abstract][Full Text] [Related]
4. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
Gespach C; Hui Bon Hoa D; Rosselin G
Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813
[TBL] [Abstract][Full Text] [Related]
5. Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity.
Waldman DB; Gardner JD; Zfass AM; Makhlouf GM
Gastroenterology; 1977 Sep; 73(3):518-23. PubMed ID: 892349
[No Abstract] [Full Text] [Related]
6. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart.
Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL
Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194
[TBL] [Abstract][Full Text] [Related]
7. In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion.
Onali P; Eva C; Olianas MC; Schwartz JP; Costa E
Mol Pharmacol; 1983 Sep; 24(2):189-94. PubMed ID: 6310360
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G
Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
[TBL] [Abstract][Full Text] [Related]
9. Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin.
Kimberg DV; Field M; Gershon E; Henderson A
J Clin Invest; 1974 Mar; 53(3):941-9. PubMed ID: 4359941
[TBL] [Abstract][Full Text] [Related]
10. Reversal of cyclic AMP-mediated intestinal secretion by ethacrynic acid.
al-Awqati Q; Field M; Greenough WB
J Clin Invest; 1974 Mar; 53(3):687-92. PubMed ID: 4359936
[TBL] [Abstract][Full Text] [Related]
11. Influence of vasoactive intestinal polypeptide on net water flux and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum.
Beubler E
Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):243-7. PubMed ID: 6253842
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin inhibits fluid secretion in the rat jejunum.
Dharmsathaphorn K; Sherwin RS; Dobbins JW
Gastroenterology; 1980 Jun; 78(6):1554-8. PubMed ID: 6102948
[TBL] [Abstract][Full Text] [Related]
13. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R
Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553
[TBL] [Abstract][Full Text] [Related]
14. Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine.
Camilleri M; Cooper BT; Adrian TE; Bloom SR; Chadwick VS
Gut; 1981 Jan; 22(1):14-8. PubMed ID: 6257593
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T
Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
[TBL] [Abstract][Full Text] [Related]
16. Activation of human adenylate cyclase in the upper gastrointestinal tract by vasoactive intestinal polypeptide.
Simon B; Kather H
Gastroenterology; 1978 Apr; 74(4):722-5. PubMed ID: 204535
[TBL] [Abstract][Full Text] [Related]
17. In vitro interactions of gastrointestinal hormones on cyclic adenosine 3':5'-monophosphate levels and amylase output in the rat pancreas.
Deschodt-Lanckman M; Robberecht P; De Neef P; Labrie F; Christophe J
Gastroenterology; 1975 Feb; 68(2):318-25. PubMed ID: 163779
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the VIP-stimulated cAMP pathway in rat distal colon after abdominal irradiation.
Morel E; Dublineau I; Lebrun F; Griffiths NM
Am J Physiol Gastrointest Liver Physiol; 2002 May; 282(5):G835-43. PubMed ID: 11960780
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.
Schwartz CJ; Kimberg DV; Sheerin HE; Field M; Said SI
J Clin Invest; 1974 Sep; 54(3):536-44. PubMed ID: 4369434
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin inhibits interleukin 6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase.
Grimaldi M; Florio T; Schettini G
Biochem Biophys Res Commun; 1997 Jun; 235(1):242-8. PubMed ID: 9196070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
